Susanne Picard, founder and president at SPharm, speaks about how her passion for regulatory affairs led her to found her own consultancy in 1997 and how the company can look back at an impressive track record of success over the last 21 years. Here, she outlines key priorities to further internationalize the scope of her activities and discusses the sector at large.
Can you please introduce SPharm to our international audience?
"Results do speak for themselves as close to 100 percent of the dossiers that myself or my team have supported through the Health Canada review process were eventually approved."
